Immix Biopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4 |
Gross Profit | -24 | -23 | 1 | |
EBITDA | -7,369 | -4,678 | -5,587 | -5,144 |
EBIT | -7,394 | -4,702 | -5,610 | -5,147 |
Net Income | -7,149 | -4,392 | -5,258 | -5,089 |
Net Change In Cash | 0 | 0 | 0 | 4 |
Free Cash Flow | -4,307 | -5,353 | -4,128 | -2,690 |
Cash | 19,690 | 23,975 | 29,319 | 17,509 |
Basic Shares | 29,424 | 28,785 | 23,438 | 19,922 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-89,517 | $0 | $0 |
Gross Profit | -5 | -89,519 | -2 | -2 |
EBITDA | -16,135 | -8,216 | -1,349 | -451 |
EBIT | -16,141 | -8,218 | -1,352 | -453 |
Net Income | -15,426 | -8,229 | -24,383 | -1,147 |
Net Change In Cash | 0 | -89,517 | 0 | 0 |
Free Cash Flow | -11,423 | -7,408 | -1,590 | -404 |
Cash | 17,509 | 13,436 | 17,644 | 391 |
Basic Shares | 17,341 | 13,228 | 13,228 | 7,773 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.24 |
2024-06-30 | -$0.15 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.23 |
